Yi Zhao

Company: Sino Cell Biomed

Job title: Chief Executive Officer

Seminars:

Accelerating TIL Manufacturing Turnaround & Improving Safety with the FAST-TIL Platform 2:30 pm

Presenting a manufacturing platform, achieving 13-19-day turnaround with a closed system to enhance safety and consistency Highlighting Phase I clinical results showing strong efficacy and a favorable safety profile, with reduced lymphodepletion and IL-2 dosing Exploring how streamlined CMC processes support rapid, scalable, and patient-friendly TIL therapy deliveryRead more

day: Conference Day One CMC Track PM